Stocktoria

Context Therapeutics Inc. CNTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-10-20

Context Therapeutics Inc. statistics & valuation

Market cap$53.3M
P / B0.9×
Return on equity-59.7%
Return on capital-65.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-21.70% -42.70% -201.90% -28.10% -59.70% 202020212022202320242025
Shares outstanding
2.1M 16.0M 16.0M 16.0M 89.7M 95.2M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
1421.80% -20.40% -39.10% -149.20% -27.20% -52.70% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$3.96 -$3.69 -$0.93 -$1.50 -$0.46 -$0.38 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-52.7%-27.2%-149.2%-39.1%-20.4%1421.8%
Return on equity-59.7%-28.1%-201.9%-42.7%-21.7%-39.3%
Current ratio8.5235.623.8311.8016.900.03

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.